ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 231 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,221,000 | -29.2% | 23,893 | -54.6% | 0.00% | -33.3% |
| Q3 2021 | $3,137,000 | +15.5% | 52,671 | +32.3% | 0.00% | 0.0% |
| Q2 2021 | $2,715,000 | -13.9% | 39,815 | -12.4% | 0.00% | 0.0% |
| Q1 2021 | $3,154,000 | -92.6% | 45,453 | -91.8% | 0.00% | -93.6% |
| Q4 2020 | $42,481,000 | +2.5% | 552,926 | -0.3% | 0.05% | -11.3% |
| Q3 2020 | $41,463,000 | +7.1% | 554,379 | -9.9% | 0.05% | +1.9% |
| Q2 2020 | $38,730,000 | -37.2% | 615,250 | -58.1% | 0.05% | 0.0% |
| Q1 2020 | $61,718,000 | +81.9% | 1,469,464 | +96.7% | 0.05% | +26.8% |
| Q4 2019 | $33,937,000 | -0.5% | 747,182 | +0.2% | 0.04% | -6.8% |
| Q3 2019 | $34,121,000 | -15.9% | 745,485 | +7.7% | 0.04% | -46.3% |
| Q2 2019 | $40,576,000 | +34.0% | 692,070 | +2.5% | 0.08% | +18.8% |
| Q1 2019 | $30,270,000 | – | 675,210 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |